Oral live attenuated human rotavirus vaccine (RotarixTM) offers sustained high protection against severe G9P[8] rotavirus gastroenteritis during the first two years of life in Brazilian children
In a large Phase III trial conducted in 10 Latin American countries, the safety and efficacy of the live attenuated monovalent rotavirus vaccine RIX4414 was evaluated in 15,183 healthy infants followed up during the first two years of life. Belém was the only site in Brazil included in this multicen...
| Autor principal: | JUSTINO, Maria Cleonice Aguiar |
|---|---|
| Outros Autores: | ARAÚJO, Eliete da Cunha, VAN DOORN, Leen-Jan, OLIVEIRA, Consuelo Silva de, GABBAY, Yvone Benchimol, MASCARENHAS, Joana D'Arc Pereira, MIRANDA, Yllen Stefania Affonso, GUERRA, Sylvia de Fátima dos Santos, SILVA, Veronilce Borges da, LINHARES, Alexandre da Costa |
| Grau: | Artigo |
| Idioma: | eng |
| Publicado em: |
2015
|
| Assuntos: | |
| Acesso em linha: |
http://repositorio.ufpa.br/jspui/handle/2011/7002 |